Winclove Bio Industries BV   Report issue

For profit Phase 4
Founded: Amsterdam Netherlands (1991)
Status: No NME R&D (1991)

Organization Overview

First Clinical Trial
2008
NCT00702026
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Winclove | Winclove Bio Industries BV | Winclove Probiotics | Winclove Probiotics B.V.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Polycystic Ovary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 15